MYLAN 7025 MYLAN 7025 (Loxapine 25 mg)
Pill imprint MYLAN 7025 MYLAN 7025 has been identified as Loxapine 25 mg.
Loxapine is used in the treatment of schizophrenia; agitated state; agitation and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 7025 MYLAN 7025
- Strength:
- 25 mg
- Color:
- Green / Brown
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-7025
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
magnesium stearate
sodium lauryl sulfate
magnesium silicate
ferrosoferric oxide
FD&C Blue No. 1
gelatin
titanium dioxide
ferric oxide yellow
D&C Yellow No. 10
FD&C Green No. 3
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0902 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about loxapine
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
